Literature DB >> 8440893

Cyclosporin A prolongs human hair growth in vitro.

M Taylor1, A T Ashcroft, A G Messenger.   

Abstract

We studied the effect of cyclosporin A on human hair growth using a recently described model in which isolated hair follicles are grown in vitro. Cyclosporin A had no effect on the rate of hair growth, but at 10(-7) M, a dose within the therapeutic blood range, it maintained hair growth for longer than control to give a 42% greater mean follicle elongation after 15 d (p < 0.05). Eighteen of 42 cyclosporin-treated follicles (43%) were still growing after 15 d compared with one of 42 control follicles (2%). These results suggest that the hypertrichotic action of cyclosporin A may be due to prolongation of the anagen phase of the hair-growth cycle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440893     DOI: 10.1111/1523-1747.ep12468979

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

Review 1.  Protection against chemotherapy-induced alopecia.

Authors:  Jie Wang; Ze Lu; Jessie L-S Au
Journal:  Pharm Res       Date:  2006-11       Impact factor: 4.200

Review 2.  A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.

Authors:  Christopher John Dunnill; Wafaa Al-Tameemi; Andrew Collett; Iain Stuart Haslam; Nikolaos Theodoros Georgopoulos
Journal:  Oncologist       Date:  2017-09-26

3.  Re-Evaluating Cyclosporine A as a Hair Growth-Promoting Agent in Human Scalp Hair Follicles.

Authors:  Nathan J Hawkshaw; Iain S Haslam; David M Ansell; Asim Shamalak; Ralf Paus
Journal:  J Invest Dermatol       Date:  2015-03-31       Impact factor: 8.551

4.  Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT).

Authors:  Danbee Kang; Im-Ryung Kim; Yeon Hee Park; Young Hyuck Im; Di Zhao; Eliseo Guallar; Jin Seok Ahn; Juhee Cho
Journal:  Support Care Cancer       Date:  2019-07-23       Impact factor: 3.603

Review 5.  A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine.

Authors:  Sonia Pandey; Purnima Tripathi; Arti Gupta; Jitendra Singh Yadav
Journal:  Drug Deliv Transl Res       Date:  2021-09-22       Impact factor: 4.617

6.  Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata.

Authors:  In Kwon Yeo; Eun Jung Ko; Yeon A No; Ee Seok Lim; Kui Young Park; Kapsok Li; Beom Joon Kim; Seong Jun Seo; Myeung Nam Kim; Chang Kwun Hong
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

7.  A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata.

Authors:  Yong Hyun Jang; Sang Lim Kim; Kyou Chae Lee; Min Ji Kim; Kyung Hea Park; Weon Ju Lee; Seok-Jong Lee; Do Won Kim
Journal:  Ann Dermatol       Date:  2016-09-30       Impact factor: 1.444

8.  Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles.

Authors:  Nathan J Hawkshaw; Jonathan A Hardman; Iain S Haslam; Asim Shahmalak; Amos Gilhar; Xinhong Lim; Ralf Paus
Journal:  PLoS Biol       Date:  2018-05-08       Impact factor: 8.029

9.  Cyclosporine A stimulated hair growth from mouse vibrissae follicles in an organ culture model.

Authors:  Wenrong Xu; Weixin Fan; Kun Yao
Journal:  J Biomed Res       Date:  2012-03-29

10.  Combination therapy with cyclosporine and psoralen plus ultraviolet a in the patients with severe alopecia areata: a retrospective study with a self-controlled design.

Authors:  Kui Young Park; Woo Sun Jang; In Pyeong Son; Sun Young Choi; Moo Yeol Lee; Beom Joon Kim; Myeung Nam Kim; Byung In Ro
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.